Morepen Laboratories
MOREPENLAB · Pharma > Pharmaceuticals & Drugs · Chairman: Sushil Suri · MD: Sushil Suri · Listing date: May 10, 1995 · Employees: 1510 · New Delhi · http://www.morepen.com

Stock Price vs Company Growth
1d
1.0%
1w
3.6%
1m
11.3%
3m
13.8%
6m
32.7%
1y
50.1%
5y
7.2%
10y
3.3%
all
6.1%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowMar08Sep11Mar15Sep18Mar22Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

42.8 1.0%
42.5
55.5
Company Overview

Sales
1,755 Cr
Growth: 2.9%
Profit after Tax
72.8 Cr
Growth: -21.4%
Small Cap
2,343 Cr
P/E: 23.9x
Industry P/E: 33.0x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 1,755
Growth 2.9%
EBITDA 7.6%
P/S 1.3x
Dividend 0.0%
P/E 23.9x
Book Value ₹ 21.6
PEG Ratio 8.3x
ROE 6.5%
P/B 2.0x
Shareholding Pattern

Institutions
Pinfold Overseas Limited
8.57 %
Ferry Holdings Limited
4.45 %
Damodar Prasad Agarwal
1.63 %
Morepen Laboratories Limited
1.25 %
Created with Highcharts 8.2.2Sep20Dec20Mar21Jun21Sep21Mar22Jun22Sep22Dec24
Promoters
Scope Credits & Financial Services Pvt. Ltd.
2.68 %
Concept Credits & Consultants Pvt. Ltd.
2.63 %
Brook Investments & Financial Services Pvt. Ltd.
2.59 %
Solitary Investments & Financial Services Pvt. Ltd
2.58 %
Solace Investments & Financial Services Pvt. Ltd.
2.57 %
Created with Highcharts 8.2.2Sep20Dec20Mar21Jun21Sep21Mar22Jun22Sep22Dec24
Others
Created with Highcharts 8.2.2Sep20Dec20Mar21Jun21Sep21Mar22Jun22Sep22Dec24
Increase    Decrease    No change
Company Profile Detailed

Established in the year 1984, Morepen Laboratories is a fast growing Pharmaceutical company listed in all major stock exchanges in India including Bombay Stock Exchange (BSE) and National Stock Exchange (NSE) since 1993 with an investors base of 62,400 shareholders.Morepen has steadily grown from a single product company to a multi activity company with a global vision and satisfied customers in over 50 countries.
Investors (83)
Followers (12)